SensiGen, LLC

SensiGen is a biotechnology company focused on gene-based molecular diagnostics. The Company develops advanced high value diagnostic tests to enable early detection of diseases, aimed at improving standards of care and reducing overall health care costs. Current products in development include tests for early detection of human papillomavirus (HPV), the primary cause of cervical cancer, Chronic Kidney Disease (CKD), Lupus, and others. SensiGen's proprietary molecular diagnostic assays offer dramatic improvements over current methods.